30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ocumension Therapeutics

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -36% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ocumension Therapeutics's trades of EyePoint Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-16 2024-01-11
US EyePoint Inc (EYPT)
S Sale
3,787 +27.6%
165.37
US$23,741 		3,787 +27.6% 165.37 US$23,741
2024-01-11 2024-01-11
US EyePoint Inc (EYPT)
PrS Proposed sale
23,680
387.61
US$1,904,968 		23,680 387.61 US$1,904,968
2023-12-07 2023-12-06
US EyePoint Inc (EYPT)
S Sale
3,855 +46.5%
153.15
US$1,212,099 		3,855 +46.5% 153.15 US$1,212,099
2023-12-07 2023-12-05
US EyePoint Inc (EYPT)
S Sale
733,758 -24.4%
19.91
US$14,609,122 		733,758 -24.4% 19.91 US$14,609,122
2023-12-05 2023-12-05
US EyePoint Inc (EYPT)
PrS Proposed sale
1,000,000
18.34
US$18,340,000 		1,000,000 18.34 US$18,340,000
2023-05-26 2023-05-26
US EyePoint Inc (EYPT)
PrS Proposed sale
3,010,722
5.93
US$17,853,581 		3,010,722 5.93 US$17,853,581
2023-05-26 2023-05-26
US EyePoint Inc (EYPT)
PrS Proposed sale
1
5.93
US$6 		1 5.93 US$6
2023-05-26 2023-05-26
US EyePoint Inc (EYPT)
PrS Proposed sale
1
5.93
US$6 		1 5.93 US$6